GGrantIndex
Sort

35,931 grants matching parkinsons

Effects of a null mutation of the tumor suppressor gene PTEN in dopamine neurons

$454,848
Cristina Backman · National Institute On Drug Abuse · Z01 · FY2007 · DA

Neural mechanisms of auditory feedback during speech

$454,789
Srikantan S Nagarajan · University Of California, San Francisco · R01 · FY2007 · DC

The Nrf2-ARE pathway in modulating Parkinson's Disease

$454,758
Jeffrey A Johnson · University Of Wisconsin-Madison · R01 · FY2010 · ES

Neural mechanisms of auditory feedback during speech

$454,726
Srikantan S Nagarajan · University Of California, San Francisco · R01 · FY2006 · DC

GABA Channel Activation Domains and Mechanisms

$454,713
David S Weiss · University Of Texas Hlth Science Center · R01 · FY2011 · NS

TGF Beta-activated Kinase and Cardiac Muscle

$454,694
Baylor College Of Medicine · R01 · FY2004 · HL

Neurochemical closed-loop controller for smart DBS

$454,658
Luis Lujan · Mayo Clinic Rochester · R01 · FY2017 · NS

Genetic analysis in families with neurological disease

$454,602
Andrew Singleton · National Institute On Aging · ZIA · FY2013 · AG

Pharmacology and Regulation of Nicotinic Receptor Subtypes

$454,584
Kenneth J Kellar · Georgetown University · R01 · FY2009 · DA

Imaging of cholinergic systems in PD

$454,519
Nicolaas Ida Bohnen · University Of Michigan At Ann Arbor · P50 · FY2015 · NS

Determining how redox changes affect optic tectum circuitry development and behavior.

$454,500
Arminda Suli · Brigham Young University · R15 · FY2024 · NS

Cell Type Specific Genetic Manipulation to Dissect Cholinergic Interneuron Function and Plasticity in a Symptomatic Model of DYT1 Dystonia

$454,382
William T Dauer · Ut Southwestern Medical Center · R01 · FY2025 · NS

The iron modulatory function of prion protein and prion disorders

$454,331
Neena Singh · Case Western Reserve University · R01 · FY2015 · NS

Investigation of the yeast prion factor [PSI+]

$453,994
Susan W. Liebman · University Of Illinois At Chicago · R01 · FY2009 · GM

SURGICAL TREATMENT OF CARDIAC ARRHYTHMIAS

$453,903
Ralph J Damiano · Washington University · R01 · FY2011 · HL

SURGICAL TREATMENT OF CARDIAC ARRHYTHMIAS

$453,902
Ralph J Damiano · Washington University · R01 · FY2012 · HL

Prospective study of biomarkers and risk factors for ALS incidence and progressio

$453,864
Alberto Ascherio · Harvard School Of Public Health · R01 · FY2016 · NS

Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease

$453,782
Laurie H Sanders · Duke University · R01 · FY2023 · NS

Acquisition of a FLIPR 3 system (384-well Type B head)

$453,690
Vanderbilt University · S10 · FY2004 · RR

Establishing the clinical utility of sensorimotor adaptation for speech rehabilitation

$453,689
Caroline Niziolek · University Of Wisconsin-Madison · R01 · FY2023 · DC

Design and characterization of Nanobodies to dementia-related α-synuclein strains in Parkinson’s disease

$453,658
Wenjing Wang · University Of Michigan At Ann Arbor · R21 · FY2021 · AG

IMPACT OF CHRONIC GDNF ON RECOVERY FROM 6-OHDA

$453,641
Children'S Memorial Hospital (Chicago) · R01 · FY2000 · NS

The Role of Drosha in the Pathogenesis of Alzheimer's Disease

$453,635
Zixu Mao · Emory University · R01 · FY2017 · NS

Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease

$453,632
John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK

Novel Neuroprotective Treatment for Parkinson's Disease

$453,516
Aloke K Dutta · Wayne State University · R01 · FY2015 · NS